Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Payables (2016 - 2025)

Historic Payables for Marimed (MRMD) over the last 15 years, with Q3 2025 value amounting to $13.6 million.

  • Marimed's Payables fell 2183.93% to $13.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.6 million, marking a year-over-year decrease of 2183.93%. This contributed to the annual value of $18.3 million for FY2024, which is 8834.84% up from last year.
  • Marimed's Payables amounted to $13.6 million in Q3 2025, which was down 2183.93% from $14.6 million recorded in Q2 2025.
  • Marimed's 5-year Payables high stood at $18.8 million for Q1 2025, and its period low was $4.8 million during Q1 2023.
  • For the 5-year period, Marimed's Payables averaged around $10.6 million, with its median value being $8.7 million (2023).
  • In the last 5 years, Marimed's Payables crashed by 7590.56% in 2021 and then skyrocketed by 13766.81% in 2024.
  • Quarter analysis of 5 years shows Marimed's Payables stood at $6.5 million in 2021, then surged by 59.78% to $10.4 million in 2022, then fell by 6.5% to $9.7 million in 2023, then soared by 88.35% to $18.3 million in 2024, then fell by 25.94% to $13.6 million in 2025.
  • Its last three reported values are $13.6 million in Q3 2025, $14.6 million for Q2 2025, and $18.8 million during Q1 2025.